| A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation X Li, N Rydzewski, A Hider, X Zhang, J Yang, W Wang, Q Gao, X Cheng, ... Nature cell biology 18 (4), 404-417, 2016 | 378 | 2016 |
| Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma NR Rydzewski, MS Lesniak, JP Chandler, JA Kalapurakal, E Pollom, ... Cancer 124 (4), 734-742, 2018 | 86 | 2018 |
| The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011 J Feinglass, N Rydzewski, A Yang Annals of epidemiology 25 (8), 549-555, 2015 | 59 | 2015 |
| Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study NR Rydzewski, AE Strohl, ED Donnelly, MJ Kanis, JR Lurain, ... Cancer 122 (23), 3724-3731, 2016 | 33 | 2016 |
| Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: a National Cancer Database study NR Rydzewski, MJ Kanis, ED Donnelly, JR Lurain, JB Strauss Radiotherapy and Oncology 129 (3), 534-539, 2018 | 25 | 2018 |
| Prognosis associated with luminal and basal subtypes of metastatic prostate cancer R Aggarwal, NR Rydzewski, L Zhang, A Foye, W Kim, KT Helzer, ... JAMA oncology 7 (11), 1644-1652, 2021 | 23 | 2021 |
| Longitudinal molecular profiling of circulating tumor cells in metastatic renal cell carcinoma M Bootsma, RR McKay, H Emamekhoo, RM Bade, JL Schehr, ... Journal of Clinical Oncology 40 (31), 3633, 2022 | 18 | 2022 |
| Predicting cancer drug TARGETS-treatment response generalized elastic-neT signatures NR Rydzewski, E Peterson, JM Lang, M Yu, S Laura Chang, M Sjöström, ... NPJ genomic medicine 6 (1), 76, 2021 | 14 | 2021 |
| Expression and therapeutic targeting of TROP-2 in treatment-resistant prostate cancer JM Sperger, KT Helzer, CN Stahlfeld, D Jiang, A Singh, KR Kaufmann, ... Clinical Cancer Research 29 (12), 2324-2335, 2023 | 9 | 2023 |
| Mortality after stereotactic radiosurgery for brain metastases and implications for optimal utilization: a national cancer database study NR Rydzewski, AJ Khan, JB Strauss, SJ Chmura American journal of clinical oncology 41 (11), 1142-1147, 2018 | 9 | 2018 |
| A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer SG Zhao, JM Sperger, JL Schehr, RR McKay, H Emamekhoo, A Singh, ... The Journal of Clinical Investigation 132 (21), 2022 | 8 | 2022 |
| National evaluation of the new commission on cancer quality measure for postmastectomy radiation treatment for breast cancer CA Minami, KY Bilimoria, NM Hansen, JB Strauss, JP Hayes, ... Annals of surgical oncology 23, 2446-2455, 2016 | 7 | 2016 |
| Intrinsic molecular subtypes of metastatic castration-resistant prostate cancer E Feng, NR Rydzewski, M Zhang, A Lundberg, M Bootsma, KT Helzer, ... Clinical Cancer Research 28 (24), 5396-5404, 2022 | 5 | 2022 |
| Identification of phenocopies improves prediction of targeted therapy response over DNA mutations alone H Bakhtiar, KT Helzer, Y Park, Y Chen, NR Rydzewski, ML Bootsma, ... NPJ Genomic Medicine 7 (1), 58, 2022 | 4 | 2022 |
| Fragmentomic analysis of circulating tumor DNA-targeted cancer panels KT Helzer, MN Sharifi, JM Sperger, Y Shi, M Annala, ML Bootsma, ... Annals of Oncology 34 (9), 813-825, 2023 | 3 | 2023 |
| Clinical implications of scleroderma in the decision for radiotherapy-based larynx preservation NR Rydzewski, PM Harari, GK Hartig, D Francis, ME Witek JAMA Otolaryngology–Head & Neck Surgery 146 (3), 308-309, 2020 | 2 | 2020 |
| A Phase 1 Trial of Focal Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer KR Patel, NR Rydzewski, E Schott, T Cooley-Zgela, H Ning, J Cheng, ... Practical Radiation Oncology 13 (6), 540-550, 2023 | 1 | 2023 |
| Radiomic modeling of bone density and rib fracture risk after stereotactic body radiation therapy for early-stage non-small cell lung cancer NR Rydzewski, P Yadav, HB Musunuru, KM Condit, D Francis, SG Zhao, ... Advances in Radiation Oncology 7 (3), 100884, 2022 | 1 | 2022 |
| Comparative Evaluation of LLMs in Clinical Oncology NR Rydzewski, D Dinakaran, SG Zhao, E Ruppin, B Turkbey, DE Citrin, ... NEJM AI, AIoa2300151, 2024 | | 2024 |
| A platform-independent AI tumor lineage and site (ATLAS) classifier NR Rydzewski, Y Shi, C Li, MR Chrostek, H Bakhtiar, KT Helzer, ... Communications Biology 7 (1), 314, 2024 | | 2024 |
